辅助生殖技术纳入医保政策的优化路径研究OA
Optimization pathway to include assisted reproductive technology in medical insurance policies
探讨在生育友好型社会建设背景下,如何加大辅助生殖技术医保政策的支持力度,以促进人口长期均衡发展.通过回顾我国辅助生殖技术政策的发展历程及纳入医保政策现状,归纳当前辅助生殖技术医保政策面临医保基金承受能力不足、地方财政与政策差异、技术项目纳入滞后以及配套监管制度不完善等挑战,提出我国辅助生殖技术纳入医保政策的优化路径应构建多层次医保制度体系、强化财政统筹与区域协调、建立科学的项目准入机制、健全配套监管体系.
This study examined strategies to strengthen medical insurance support for assisted reproductive technology(ART)within the context of building a fertility-friendly society,aiming to promote long-term balanced population development.By reviewing the evolution of ART policies in China and their current inclusion in insur-ance schemes,the study identified key challenges,including limited insurance fund capacity,regional fiscal and policy disparities,delayed coverage of new technologies,and insufficient regulatory oversight.To address these is-sues,the study proposed a set of optimization strategies:establishing a multi-tiered insurance system,enhancing fiscal coordination and regional policy alignment,implementing a scientific project inclusion mechanism,and im-proving supporting regulatory frameworks.
牛雨涵;刘健;黄心如;张学宁;谈在祥
徐州医科大学公共卫生学院,江苏徐州 221004徐州医科大学公共卫生学院,江苏徐州 221004徐州医科大学管理学院江苏省卫生健康发展研究中心徐州医科大学管理学院||徐州医科大学卫生政策与健康管理研究中心||徐州医科大学附属医院
医药卫生
生育友好型社会辅助生殖技术医疗保险不孕不育优化路径生育支持
Fertility-friendly societyAssisted reproductive technologyMedical insuranceInfertilityOptimization pathwayFertility support
《中国农村卫生事业管理》 2026 (7)
476-480,5
国家社会科学基金项目(25BGL229)江苏省卫生健康发展研究中心课题一般项目(JSHD202308)江苏省科教能力提升工程专项经费资助(ZDXYS202210)
评论